Low-energy defibrillation of ventricular fibrillati-on in pigs as an animal model for heart failure

In order to translate these results successfully into clinical application, the necessary proof of efficacy in an animal model is to be produced in the scope of this project: the termination of ventricular fibrillation by means of a novel defibrillator compared to conventional defibrillation will be examined in pigs used as an animal model for heart failure. The results will constitute the foundation for preparing a study for a first-in-human application
- Project Term
- 2016 - 2019
- Granted Budget
- € 1.021.091
- Indication
- ventricular fibrillation
- Therapeutic Principle
- Medicinal Product
- Principal Investigator
- Stefan Luther, Gerd Hasenfuß (Max Planck Institute for Dynamics and Self-Organisation, University Medical Centre Göttingen)